Skip to main content
OIDA Image Collection
Filters:
Reset 
This is a chart showing whether patients prefer deutetrabenazine (DTB) or a placebo. The top half of the chart shows preferences for 3 different doses of DTB (12 mg/day 24 mg/day 36 mg/day) vs. a placebo for patients with Psychotic disorders and the bottom half of the chart shows preferences for 3 different doses of DTB (12 mg/day 24 mg/day 36 mg/day) vs. a placebo for patients with Mood disorders. Patients with Psychotic disorders prefer DTB at the 12 mg/day dose and the 24 mg/day dose but prefer the placebo at the 36 mg/day dose; patients with Mood disorders prefer DTB at the 24 mg/day dose and the 36 mg/day dose but prefer the placebo at the 12 mg/day dose.

Title

Preference for deutetrabenazine vs. placebo in patients with both Psychotic disorders and Mood disorders

Description

This is a chart showing whether patients prefer deutetrabenazine (DTB) or a placebo. The top half of the chart shows preferences for 3 different doses of DTB (12 mg/day 24 mg/day 36 mg/day) vs. a placebo for patients with Psychotic disorders and the bottom half of the chart shows preferences for 3 different doses of DTB (12 mg/day 24 mg/day 36 mg/day) vs. a placebo for patients with Mood disorders. Patients with Psychotic disorders prefer DTB at the 12 mg/day dose and the 24 mg/day dose but prefer the placebo at the 36 mg/day dose; patients with Mood disorders prefer DTB at the 24 mg/day dose and the 36 mg/day dose but prefer the placebo at the 12 mg/day dose.

Type Generated using AI

Category

We encourage you to view the image in the context of its source document(s) and cite the source(s) when using these images. However, to cite just this image alone, click the “Cite This Image” button and then paste the copied text.

Cite This Image

Information copied to your clipboard:

"Preference for deutetrabenazine vs. placebo in patients with both Psychotic disorders and Mood disorders." OIDA Image Collection. Available at https:...